HWM
MRNA icon

Hemington Wealth Management’s Moderna MRNA Stock Holding History

Hemington Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$0 Buy
16
+5
+45% +$139 ﹤0.01% 1649
2025
Q2 		$0 Sell
11
-17
-61% -$448 ﹤0.01% 1641
2025
Q1 		$0 Sell
28
-16
-36% -$568 ﹤0.01% 1657
2024
Q4 		$1K Buy
44
+37
+529% +$1.77K ﹤0.01% 1434
2024
Q3 		$0 Buy
+7
New +$643 ﹤0.01% 1648

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Hemington Wealth Management's MRNA Position: Q3 2025 in Review

Hemington Wealth Management increased its Moderna (MRNA) stake by 45% in Q3 2025, buying an estimated $139 and bringing the position to 16 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

Hemington Wealth Management first reported a position in MRNA in Q3 2024 and has held it in 5 quarters since. The position peaked at $1K in Q4 2024. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Hemington Wealth Management held 16 shares of Moderna worth $0 as of Q3 2025.
  • Hemington Wealth Management bought 5 Moderna shares in Q3 2025, an estimated $139.
  • Moderna made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1649 holding.
  • Hemington Wealth Management first reported a position in Moderna in Q3 2024 and has held it in 5 quarters since.
  • Hemington Wealth Management's Moderna position peaked at $1K in Q4 2024.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.